Cargando…
Negative Immune Checkpoint Protein, VISTA, Regulates the CD4(+) T(reg) Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival
Sepsis is a systemic immune response to infection that is responsible for ~35% of in-hospital deaths and over 24 billion dollars in annual treatment costs. Strategic targeting of non-redundant negative immune checkpoint protein pathways can cater therapeutics to the individual septic patient and imp...
Autores principales: | Gray, Chyna C., Biron-Girard, Bethany, Wakeley, Michelle E., Chung, Chun-Shiang, Chen, Yaping, Quiles-Ramirez, Yael, Tolbert, Jessica D., Ayala, Alfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988198/ https://www.ncbi.nlm.nih.gov/pubmed/35401514 http://dx.doi.org/10.3389/fimmu.2022.861670 |
Ejemplares similares
-
The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
por: Hensler, Emily, et al.
Publicado: (2022) -
Biomarkers for Sepsis: What Is and What Might Be?
por: Biron, Bethany M., et al.
Publicado: (2015) -
Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression
por: Wakeley, Michelle E., et al.
Publicado: (2023) -
Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis
por: Fallon, Eleanor A., et al.
Publicado: (2017) -
PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012)